Lenvatinib Sandoz 4 mg, harde capsules

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h133314_smpc_en.pdf",
  "strength": null,
  "atc_label": "Lenvatinib",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg133314",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "HYDROXYPROPYLCELLULOSE, LAAG GESUBSTITUEERD (E 463a)",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "KALIUMHYDROXIDE (E 525)",
    "MANNITOL (D-) (E 421)",
    "NATRIUMWATERSTOFCARBONAAT (E 500 (II))",
    "SCHELLAK (E 904)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)",
    "ZWARTE INKT"
  ],
  "substances": [
    "LENVATINIBBESILAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h133314_piluk.pdf",
  "authorised_at": "2025/10/07",
  "procedure_number": "NL/H/6109/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "133314",
  "additional_monitoring": "N"
}